Literature DB >> 24957094

Laboratory diagnosis of mucormycosis: current status and future perspectives.

Michaela Lackner1, Rita Caramalho, Cornelia Lass-Flörl.   

Abstract

Fungal infections caused by members of the Mucorales order are rapidly progressing and fatal. The importance of mucormycosis has grown in recent years as the number of patients with predisposing factors has increased dramatically. Clinical symptoms are elusive and conventional techniques are often insensitive and unspecific; in particular, cultures are often negative even though direct microscopy is positive. For early diagnosis of the causative agent of disease and subsequently guiding therapy to improving patients' outcome, molecular assays are promising add-ons. This article provides an overview on current laboratory methods for diagnosing mucormycosis with a special focus on new molecular-based tools. We aim to highlight the pros and cons of various techniques at hand. Given the increase in number and the severity of these infections, molecular approaches for improved diagnosis are highly warranted.

Entities:  

Keywords:  PCR; internal transcribed spacer; matrix-assisted laser desorption ionization time of flight; molecular diagnosis; mucorales; mucormycosis; species identification

Mesh:

Substances:

Year:  2014        PMID: 24957094     DOI: 10.2217/fmb.14.23

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  37 in total

1.  Etest cannot be recommended for in vitro susceptibility testing of mucorales.

Authors:  Rita Caramalho; Elisabeth Maurer; Ulrike Binder; Ricardo Araújo; Somayeh Dolatabadi; Cornelia Lass-Flörl; Michaela Lackner
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

Review 2.  Challenges in the diagnosis and treatment of mucormycosis.

Authors:  A Skiada; C Lass-Floerl; N Klimko; A Ibrahim; E Roilides; G Petrikkos
Journal:  Med Mycol       Date:  2018-04-01       Impact factor: 4.076

3.  Spondylodiscitis associated with skin lesions caused by Rhizopus in a patient with systemic lupus erythematosus.

Authors:  Larissa Silva de Saboya; Moara Alves Santa Bárbara Borges; Diego Gonçalves Camargo; Maria Auxiliadora de Paula Carneiro Cysneiros; Murilo Eugênio Oliveira; Adriana Oliveira Guilarde
Journal:  Infez Med       Date:  2022-03-01

4.  Optimization of a Quantitative PCR Methodology for Detection of Aspergillus spp. and Rhizopus arrhizus.

Authors:  Alexandre Mendonça; Joana Carvalho-Pereira; Ricardo Franco-Duarte; Paula Sampaio
Journal:  Mol Diagn Ther       Date:  2022-06-16       Impact factor: 4.476

5.  Rhino-Orbital Mucormycosis After COVID-19 Recovery: A Case Report.

Authors:  Ana Filipa Moleiro; Ana Maria Cunha; Rodrigo Vilares-Morgado; António José Cruz; Ana Isabel Almeida; Fernanda Peixoto; Fernando Falcão-Reis; Jorge Meira; Vítor Leal
Journal:  Int Med Case Rep J       Date:  2022-10-14

6.  Battling the emerging epidemic of rhino-orbital-cerebral mucormycosis (ROCM) in COVID-19 pandemic: an interventional study.

Authors:  Aastha Gandhi; Anurag Narula; Shreya Chandra; Dhwanee Agarwal; Anuj Mehta; Shaktiprada Nayak; Sheetal Arora; Malini R Capoor
Journal:  Int Ophthalmol       Date:  2022-10-23       Impact factor: 2.029

7.  Isolated cerebral mucormycosis caused by Rhizomucor pusillus.

Authors:  Saira Farid; Omar AbuSaleh; Rachael Liesman; Muhammad Rizwan Sohail
Journal:  BMJ Case Rep       Date:  2017-10-04

Review 8.  Recent trends in molecular diagnostics of yeast infections: from PCR to NGS.

Authors:  Toni Gabaldón
Journal:  FEMS Microbiol Rev       Date:  2019-09-01       Impact factor: 16.408

9.  Medical and surgical treatment of rhino-orbital-cerebral mucormycosis in a child with leukemia.

Authors:  Mette Levinsen; Jens Folke Kiilgaard; Carsten Thomsen; Steffen Heegaard; Kamilla Rothe Nissen
Journal:  Am J Ophthalmol Case Rep       Date:  2021-04-16

10.  Molecular Identification of Mucor and Lichtheimia Species in Pure Cultures of Zygomycetes.

Authors:  Ardeshir Ziaee; Mohammadali Zia; Mansour Bayat; Jamal Hashemi
Journal:  Jundishapur J Microbiol       Date:  2016-04-09       Impact factor: 0.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.